Business Description
MedApp SA
NAICS : 519190
SIC : 8099
ISIN : PLYLWHT00012
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | 0.74 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | 0.28 | |||||
Interest Coverage | 15.35 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.78 | |||||
Beneish M-Score | -3.63 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1.4 | |||||
3-Year EBITDA Growth Rate | -6.5 | |||||
3-Year FCF Growth Rate | 17.8 | |||||
3-Year Book Growth Rate | 5.8 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 28.08 | |||||
9-Day RSI | 31.65 | |||||
14-Day RSI | 35.02 | |||||
6-1 Month Momentum % | -45.95 | |||||
12-1 Month Momentum % | -44.39 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.16 | |||||
Quick Ratio | 2.16 | |||||
Cash Ratio | 0.01 | |||||
Days Inventory | 834.75 | |||||
Days Sales Outstanding | 98.2 | |||||
Days Payable | 221.57 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.4 | |||||
Shareholder Yield % | -2.85 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 75.59 | |||||
Operating Margin % | 15.05 | |||||
Net Margin % | -32 | |||||
FCF Margin % | -17.01 | |||||
ROE % | -9.28 | |||||
ROA % | -6.52 | |||||
ROIC % | 3.74 | |||||
ROC (Joel Greenblatt) % | -97.96 | |||||
ROCE % | -6.47 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 4.66 | |||||
PS Ratio | 5.22 | |||||
PB Ratio | 1.46 | |||||
Price-to-Tangible-Book | 2.16 | |||||
EV-to-EBIT | -21.26 | |||||
EV-to-Forward-EBIT | 28.68 | |||||
EV-to-EBITDA | 7.37 | |||||
EV-to-Forward-EBITDA | 20.2 | |||||
EV-to-Revenue | 5.43 | |||||
EV-to-Forward-Revenue | 6.99 | |||||
EV-to-FCF | -31.95 | |||||
Price-to-Net-Current-Asset-Value | 5.05 | |||||
Earnings Yield (Greenblatt) % | -4.7 | |||||
FCF Yield % | -3.25 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
MedApp SA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil zł) | 7.244 | ||
EPS (TTM) (zł) | -0.01 | ||
Beta | 0.99 | ||
Volatility % | 34.08 | ||
14-Day RSI | 35.02 | ||
14-Day ATR (zł) | 0.011718 | ||
20-Day SMA (zł) | 0.163725 | ||
12-1 Month Momentum % | -44.39 | ||
52-Week Range (zł) | 0.142 - 0.419 | ||
Shares Outstanding (Mil) | 250.13 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
MedApp SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
MedApp SA Stock Events
Event | Date | Price(zł) | ||
---|---|---|---|---|
No Event Data |
MedApp SA Frequently Asked Questions
What is MedApp SA(WAR:MDA)'s stock price today?
When is next earnings date of MedApp SA(WAR:MDA)?
Does MedApp SA(WAR:MDA) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |